DDR1 and breast cancer: It has been reported that DDR1 is overexpressed in high-grade brain, esophageal, and breast cancers, and high expression of DDR1 was associated with a significantly poorer survival in several cohorts of patients with brain, breast, and lung cancers [18,22,24–26].